Veracyte Inc (VCYT)
Financial leverage ratio
Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total assets | US$ in thousands | 1,344,100 | 1,315,410 | 1,300,040 | 1,275,020 | 1,234,330 | 1,200,070 | 1,137,820 | 1,124,940 | 1,161,110 | 1,157,120 | 1,156,420 | 1,125,960 | 1,144,200 | 1,173,590 | 1,187,820 | 1,186,360 | 1,027,440 | 1,025,140 | 457,163 | 454,151 |
Total stockholders’ equity | US$ in thousands | 1,221,060 | 1,194,940 | 1,175,970 | 1,176,040 | 1,132,520 | 1,118,650 | 1,044,100 | 1,054,060 | 1,082,720 | 1,081,260 | 1,075,200 | 1,048,180 | 1,064,150 | 1,085,190 | 1,096,510 | 1,107,080 | 971,177 | 974,231 | 421,232 | 422,725 |
Financial leverage ratio | 1.10 | 1.10 | 1.11 | 1.08 | 1.09 | 1.07 | 1.09 | 1.07 | 1.07 | 1.07 | 1.08 | 1.07 | 1.08 | 1.08 | 1.08 | 1.07 | 1.06 | 1.05 | 1.09 | 1.07 |
June 30, 2025 calculation
Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $1,344,100K ÷ $1,221,060K
= 1.10
The financial leverage ratio of Veracyte Inc. has demonstrated a relatively stable pattern over the period from September 2020 through June 2025. Throughout this timeframe, the ratio consistently remained close to 1.07–1.11, indicating that the company's debt levels in relation to its equity have experienced minimal fluctuation. Notably, the ratio generally hovered just above 1.0, suggesting a moderate use of leverage where debt is slightly greater than equity but not excessively so.
In particular, the ratio reached its lowest point of approximately 1.05 in March 2021, indicating a slightly more conservative debt position at that time. Conversely, the highest observed level was approximately 1.11 in December 2024, reflecting a marginal increase in leverage, yet still within a manageable range.
The overall trend does not depict significant volatility or rapid escalation in leverage, which implies a stable approach to capital structure management. The consistent figures suggest that Veracyte Inc. maintains a steady balance between debt and equity, supporting ongoing operational stability without overly relying on debt financing. This moderate leverage profile can be viewed as prudent in terms of financial risk, aligning with a conservative strategy that aims to sustain financial flexibility over the analyzed period.
Peer comparison
Jun 30, 2025